Vaccines Market Research Reports & Industry Analysis
Key issues in the global vaccine market today include product safety, supply shortages, the use of vaccines to prevent pandemics and address bioterrorism, and innovations in vaccine delivery systems.
The topic of vaccine safety became prominent during the mid 1970’s with increases in lawsuits filed on behalf of those presumably injured by the diphtheria, pertussis, and tetanus (DPT) vaccine. To respond to public health concerns, Congress passed the National Childhood Vaccine Injury Act (NCVIA) in 1986, which in turn led to the creation of the National Vaccine Program Office (NVPO) within the Department of Health and Human Services (DHHS). NCVIA requires that all healthcare providers who administer vaccines containing diphtheria, tetanus, pertussis, polio, measles, mumps, rubella, hepatitis B, Haemophilus influenzae type b and varicella provide a Vaccine Information Statement (VIS) to the vaccine recipient, their parent or legal guardian prior to each dose. Each VIS contains a brief description of the disease as well as the risks and benefits of the vaccine. The NCVIA also mandated that all healthcare providers report certain adverse events that occur following vaccination. As a result, the Vaccine Adverse Event Reporting System (VAERS) and Vaccine Safety Datalink Project (VSD) were established in 1990. VAERS provides a mechanism for the collection and analysis of adverse events associated with vaccines currently licensed in the U.S.; VSD involved forming partnerships with four large health maintenance organizations (HMOs) to continually monitor vaccine safety. The National Vaccine Injury Compensation Program, which was also created by NCVIA, compensates those individuals who have been injured by vaccines on a no-fault basis. On a global basis, the World Health Organization (WHO) is actively involved in ensuring the quality of vaccines.
Filter your search
Research Assistance
Vaccines Industry Research & Market Reports
-
Global Dna Vaccine Market Forecast 2018-2026
... Factors like increasing investments for third-generation vaccines, increasing adoption in animal healthcare and potential application of these vaccines in identifying growing prevalence of diseases is influencing the market growth. MARKET INSIGHTS The Global DNA Vaccines ... Read More
-
Asia Pacific Dna Vaccine Market Forecast 2018-2026
... 2026, growing at a CAGR of 42.65%. MARKET INSIGHTS The Asia-Pacific market is predicted to witness the highest growth over the forecast period due to factors like increasing government backing, growing interest in third generation ... Read More
-
Europe Dna Vaccine Market Forecast 2018-2026
... of 2018-2026. MARKET INSIGHTS The fact that these vaccines are increasingly being adopted for veterinary purposes and are highly useful for keeping in check the growing prevalence of diseases is significantly driving the market growth. ... Read More
-
North America Dna Vaccine Market Forecast 2018-2026
... of $XX million by 2026. The US DNA vaccine market is expected to capture a major share of this market, followed by Canada. MARKET INSIGHTS The market is segmented according to the type of technology, ... Read More
-
Global Lyme Disease Vaccine Market Research Report 2018
... market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China). The report firstly introduced the Lyme Disease Vaccine basics: ... Read More
-
Global Polyvalent Pneumococcal Vaccine Market Research Report 2018
... market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China). The report firstly introduced the Polyvalent Pneumococcal Vaccine basics: ... Read More
-
Global Pneumococcal Polysaccharide Vaccine Market Research Report 2018
... market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China). The report firstly introduced the Pneumococcal Polysaccharide Vaccine basics: ... Read More
-
Global Vaccine Partnering Terms and Agreements 2010-2018: Deal trends, players and financials
... vaccine partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in vaccine and adjuvant partnering deals Deal terms analysis Partnering agreement structure Partnering contract documents Top deals by value Most active ... Read More
-
North America Veterinary Vaccine Adjuvants Market by Manufacturers, Countries, Type and Application, Forecast to 2023
... protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities. And many vaccines also contain an adjuvant or adjuvant combination: these are substances ... Read More
-
North America Swine Vaccines Market by Manufacturers, Countries, Type and Application, Forecast to 2023
... by neutralising the toxins that are responsible for the disease. This process of stimulating immunity is called vaccination. Scope of the Report: This report focuses on the Swine Vaccines in North America market, especially in ... Read More
-
Global Pneumococcal Vaccines Market Research Report 2018
... focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China). The report firstly introduced the Pneumococcal Vaccines basics: definitions, classifications, applications ... Read More
-
High Potency APIs /HPAPI Market by Type (Innovative, Generic), Synthesis (Synthetic, Biotech, moAB, Vaccines, Recombinant Proteins), Manufacturer (Captive and Merchant), Therapy (Oncology, Glaucoma, Hormonal Imbalance) - Global Forecasts to 2023
... projected to grow at a CAGR of 8.7%” The global HPAPIs market is expected to reach USD 26.84 billion by 2023 from USD 17.72 billion in 2018, at a CAGR 8.7%. The growth in this ... Read More
-
North America and Europe All Vaccine Market by Manufacturers, Regions, Type and Application, Forecast to 2023
... contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system ... Read More
-
Vaccine Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2023
... the global vaccine market was sized over USD 29.17 billion in 2016. The global vaccine market is projected to grow with a CAGR 5.2% in terms of value during the forecast period, 2017-2023 and reach ... Read More
-
Europe Vaccine Refrigerators Market by Manufacturers, Countries, Type and Application, Forecast to 2023
... to be held at temperatures lower than that of a conventional fridge. The unit provides extremely stable low temperatures to prevent degradation of vaccines and other products, along with options like alarms and backup power ... Read More
-
Global BCG Vaccine Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
... infection, which affects the lungs and sometimes other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of the most ... Read More
-
United States Peptide Cancer Vaccine Market by Manufacturers, States, Type and Application, Forecast to 2023
... underlying mechanism of peptide-based vaccines involves the generation of a T-cell immune response against tumor or enhancement of an endogenous antitumor immunity pre-existing in the host. Scope of the Report: This report focuses on the ... Read More
-
Asia-Pacific Swine Vaccines Market by Manufacturers, Regions, Type and Application, Forecast to 2023
... neutralising the toxins that are responsible for the disease. This process of stimulating immunity is called vaccination. Scope of the Report: This report focuses on the Swine Vaccines in Asia-Pacific market, especially in China, Japan, ... Read More
-
Asia-Pacific Veterinary Vaccine Adjuvants Market by Manufacturers, Regions, Type and Application, Forecast to 2023
... against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities. And many vaccines also contain an adjuvant or adjuvant combination: these are substances added ... Read More
-
Global Vaccine Adjuvants Market Research Report, Insights, Opportunity, Analysis, Market Shares And Forecast 2017 – 2023
... ability to induce protection against infection. The global vaccine adjuvants market is growing at a CAGR of 10.25% during forecast period 2016-2023. Increasing use of adjuvants in vaccine, high prevalence of infectious diseases and zoonotic ... Read More
-
Indian Vaccine Market Report and Forecast 2018-2023
... Currently, more than two thirds of the total volume of the vaccines manufactured is exported while the rest is utilised domestically. According to a new report by IMARC titled “Indian Vaccine Market Report and Forecast ... Read More
-
Global Infectious Vaccines Partnering Terms and Agreements 2012 to 2018: Deal trends, players and financials
... detailed understanding and analysis of how and why companies enter infectious vaccines partnering deals. The majority of deals are development stage whereby the licensee obtains a right or an option right to license the licensors ... Read More
-
Global Hepatitis A Vaccine Sales Market Report 2018
... this report analyzes the top players in global and major regions, and splits the Hepatitis A Vaccine market by product type and applications. In the last several years, global market of Hepatitis A Vaccine developed ... Read More
-
Global Preventive Vaccines Market - Segmented by Vaccine Type, Disease Indications, and Geography - Growth, Trends, and Forecast (2018 - 2023)
... during the forecast period of 2018-2023. North America is anticipated to dominate the market during the forecast period owing to technological advancement in the development of innovative vaccines in the region. Funding from Government and ... Read More
-
Global Cancer Vaccine Partnering 2012-2018: Deal trends, players, financials and forecasts
... the worlds leading healthcare companies. Trends in cancer vaccine partnering deals Disclosed headlines, upfronts, milestones and royalties by stage of development Cancer vaccine partnering contract documents Top cancer vaccine deals by value This report provides ... Read More
